If you made any changes in Pure these will be visible here soon.

Research Output

  • 1 Conference abstract in journal

An Open-Labelled, Randomized Phase II Study in Patients with Recurrent Glioblastoma Multiforme Comparing Progression Free Survival of Alecsat (Autologous Lymphoid Effector Cells Specific Against Tumour-Cells) Versus Bevacizumab/irinotecan

Haslund, C., Muhic, A., Lukacova, S., Lund, B., Lassen-Ramshad, Y., Meyer, M., Roland, M. & Poulsen, H. S., 1 Oct 2016, In : Neuro-Oncology. 18, p. iv6 1 p.

Research output: Contribution to journalConference abstract in journalResearchpeer-review